Marcella Alsan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Human Rights | 1 | 2023 | 309 | 0.690 |
Why?
|
Information Seeking Behavior | 1 | 2020 | 116 | 0.670 |
Why?
|
Drug Utilization | 2 | 2015 | 1187 | 0.660 |
Why?
|
Consumer Health Information | 1 | 2020 | 210 | 0.610 |
Why?
|
Penicillins | 1 | 2021 | 406 | 0.610 |
Why?
|
Trust | 2 | 2020 | 532 | 0.600 |
Why?
|
Drug Resistance, Microbial | 1 | 2020 | 856 | 0.560 |
Why?
|
Syphilis | 1 | 2019 | 243 | 0.560 |
Why?
|
Plasmids | 1 | 2020 | 2275 | 0.490 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5331 | 0.470 |
Why?
|
Community-Acquired Infections | 1 | 2018 | 460 | 0.470 |
Why?
|
Poverty | 3 | 2018 | 2692 | 0.450 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2018 | 586 | 0.450 |
Why?
|
Urinary Tract Infections | 1 | 2020 | 812 | 0.440 |
Why?
|
Mortality | 2 | 2021 | 2886 | 0.420 |
Why?
|
Candidiasis | 2 | 2015 | 363 | 0.420 |
Why?
|
Motivation | 2 | 2023 | 1996 | 0.400 |
Why?
|
Drug Resistance, Bacterial | 2 | 2018 | 1055 | 0.390 |
Why?
|
Attitude to Health | 1 | 2020 | 2026 | 0.360 |
Why?
|
Educational Status | 2 | 2021 | 2513 | 0.360 |
Why?
|
Lymphadenitis | 1 | 2011 | 98 | 0.360 |
Why?
|
Tularemia | 1 | 2010 | 42 | 0.350 |
Why?
|
Anti-Infective Agents | 2 | 2015 | 981 | 0.350 |
Why?
|
Bacterial Infections | 1 | 2018 | 1401 | 0.350 |
Why?
|
Seasons | 1 | 2015 | 1519 | 0.340 |
Why?
|
Public Health | 2 | 2021 | 2658 | 0.310 |
Why?
|
Candida albicans | 1 | 2011 | 374 | 0.310 |
Why?
|
Clinical Competence | 1 | 2023 | 4775 | 0.300 |
Why?
|
Developing Countries | 5 | 2022 | 2866 | 0.300 |
Why?
|
Abscess | 1 | 2010 | 605 | 0.270 |
Why?
|
Health Education | 1 | 2013 | 1049 | 0.270 |
Why?
|
Neck | 1 | 2010 | 731 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3196 | 0.260 |
Why?
|
Medication Adherence | 1 | 2017 | 2155 | 0.250 |
Why?
|
Health Status Disparities | 1 | 2017 | 1831 | 0.250 |
Why?
|
India | 3 | 2022 | 2329 | 0.240 |
Why?
|
Influenza, Human | 1 | 2015 | 1516 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10146 | 0.230 |
Why?
|
Internship and Residency | 1 | 2023 | 5865 | 0.220 |
Why?
|
Communicable Diseases | 1 | 2011 | 877 | 0.210 |
Why?
|
Jurisprudence | 1 | 2023 | 109 | 0.210 |
Why?
|
Health Expenditures | 1 | 2015 | 2347 | 0.210 |
Why?
|
Federal Government | 1 | 2024 | 267 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.200 |
Why?
|
Anti-HIV Agents | 2 | 2017 | 4504 | 0.200 |
Why?
|
Masks | 2 | 2022 | 207 | 0.200 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7403 | 0.190 |
Why?
|
Socioeconomic Factors | 4 | 2020 | 7818 | 0.180 |
Why?
|
HIV Infections | 3 | 2017 | 17275 | 0.180 |
Why?
|
Certification | 1 | 2023 | 418 | 0.180 |
Why?
|
Income | 2 | 2020 | 1872 | 0.170 |
Why?
|
Georgia | 2 | 2017 | 190 | 0.170 |
Why?
|
Italy | 1 | 2021 | 839 | 0.160 |
Why?
|
Population Dynamics | 1 | 2021 | 307 | 0.160 |
Why?
|
Knowledge | 1 | 2020 | 176 | 0.160 |
Why?
|
Typhoid-Paratyphoid Vaccines | 1 | 2018 | 39 | 0.160 |
Why?
|
Klebsiella pneumoniae | 1 | 2020 | 254 | 0.150 |
Why?
|
beta-Lactamases | 1 | 2020 | 304 | 0.150 |
Why?
|
Bacteriuria | 1 | 2018 | 103 | 0.150 |
Why?
|
Health Facilities | 1 | 2023 | 578 | 0.150 |
Why?
|
Politics | 1 | 2024 | 815 | 0.150 |
Why?
|
Humans | 27 | 2024 | 758406 | 0.150 |
Why?
|
Salmonella typhi | 1 | 2018 | 199 | 0.140 |
Why?
|
Vaccines, Conjugate | 1 | 2018 | 328 | 0.140 |
Why?
|
Typhoid Fever | 1 | 2018 | 195 | 0.140 |
Why?
|
Quinolones | 1 | 2020 | 377 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25956 | 0.140 |
Why?
|
Genes, Bacterial | 1 | 2020 | 1071 | 0.130 |
Why?
|
Culture | 1 | 2020 | 624 | 0.130 |
Why?
|
California | 1 | 2020 | 1419 | 0.130 |
Why?
|
Video Recording | 1 | 2020 | 954 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3599 | 0.130 |
Why?
|
Medicine | 1 | 2024 | 942 | 0.130 |
Why?
|
Treatment Refusal | 1 | 2017 | 429 | 0.120 |
Why?
|
Male | 15 | 2024 | 358747 | 0.110 |
Why?
|
Esophageal Diseases | 1 | 2015 | 168 | 0.110 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5404 | 0.110 |
Why?
|
Patient Participation | 1 | 2023 | 1436 | 0.110 |
Why?
|
Pandemics | 4 | 2022 | 8611 | 0.110 |
Why?
|
Incidence | 3 | 2020 | 21272 | 0.110 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2015 | 242 | 0.110 |
Why?
|
Adult | 10 | 2024 | 219935 | 0.110 |
Why?
|
Demography | 1 | 2017 | 1651 | 0.100 |
Why?
|
Minority Groups | 1 | 2019 | 1206 | 0.100 |
Why?
|
Family Characteristics | 1 | 2017 | 1000 | 0.100 |
Why?
|
Female | 14 | 2024 | 390323 | 0.100 |
Why?
|
Health Promotion | 2 | 2021 | 2204 | 0.090 |
Why?
|
Gender Identity | 1 | 2017 | 757 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2015 | 662 | 0.090 |
Why?
|
Patients | 1 | 2017 | 904 | 0.090 |
Why?
|
Fluconazole | 1 | 2011 | 155 | 0.090 |
Why?
|
Communicable Disease Control | 2 | 2022 | 842 | 0.090 |
Why?
|
Patient Selection | 1 | 2023 | 4244 | 0.090 |
Why?
|
United States | 5 | 2024 | 72136 | 0.090 |
Why?
|
Adolescent | 6 | 2020 | 87892 | 0.090 |
Why?
|
Birth Rate | 1 | 2011 | 168 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1240 | 0.090 |
Why?
|
Haiti | 1 | 2011 | 549 | 0.080 |
Why?
|
Child Mortality | 1 | 2011 | 205 | 0.080 |
Why?
|
Rwanda | 1 | 2011 | 659 | 0.080 |
Why?
|
Ciprofloxacin | 1 | 2010 | 312 | 0.080 |
Why?
|
Uganda | 1 | 2013 | 1324 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 58808 | 0.080 |
Why?
|
Escherichia coli | 1 | 2020 | 4215 | 0.070 |
Why?
|
Pregnancy | 2 | 2020 | 29742 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 7985 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1098 | 0.070 |
Why?
|
Aged | 5 | 2022 | 168218 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3992 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3242 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2011 | 749 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 1895 | 0.070 |
Why?
|
Middle Aged | 7 | 2024 | 219568 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3355 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1911 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2011 | 856 | 0.070 |
Why?
|
Health Personnel | 1 | 2019 | 3312 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 5862 | 0.060 |
Why?
|
Sex Factors | 2 | 2017 | 10504 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8553 | 0.060 |
Why?
|
Child, Preschool | 3 | 2018 | 42062 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3915 | 0.060 |
Why?
|
Reproductive Health Services | 1 | 2024 | 87 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1402 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4580 | 0.050 |
Why?
|
Prevalence | 1 | 2020 | 15651 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58683 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22029 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16534 | 0.050 |
Why?
|
Medicare | 2 | 2022 | 6741 | 0.050 |
Why?
|
Social Marketing | 1 | 2021 | 52 | 0.050 |
Why?
|
Health Behavior | 2 | 2024 | 2617 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8544 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10652 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12075 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18358 | 0.040 |
Why?
|
Cultural Competency | 1 | 2021 | 297 | 0.040 |
Why?
|
Cameroon | 1 | 2017 | 74 | 0.040 |
Why?
|
Contrast Media | 1 | 2010 | 5298 | 0.040 |
Why?
|
Child | 3 | 2022 | 79818 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12951 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11424 | 0.030 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2024 | 1196 | 0.030 |
Why?
|
Risk Factors | 2 | 2018 | 73809 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 80168 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 64378 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3175 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2569 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3846 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20500 | 0.020 |
Why?
|
Biomedical Research | 1 | 2022 | 3418 | 0.020 |
Why?
|
Viral Load | 1 | 2015 | 3321 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5484 | 0.020 |
Why?
|
Health Care Costs | 1 | 2017 | 3245 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36055 | 0.010 |
Why?
|